EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment

Francisca Cristi, Maiah Walters, Nashae Narayan, Kate Agopsowicz, Mary M Hitt, Maya Shmulevitz

Molecular Therapy - Oncolytics · 2023-12 · 31 · 100743

DOI: 10.1016/j.omto.2023.100743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy - Oncolytics, 2023-12. Verfasst von Francisca Cristi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, University of Alberta, Edmonton AB T6G 2E1, Canada. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wild-type reovirus serotype 3 Dearing (T3wt), a non-pathogenic intestinal virus, has shown promise as a cancer therapy in clinical trials, but it would benefit from an increased potency. Given that T3wt is naturally adapted to the intestinal environment (rather than tumors), we genetically modified reovirus to improve its infectivity in cancer cells. Various reovirus mutants were created, and their oncolytic potency was evaluated in vitro using plaque size as a measure of virus fitness in cancer cells. Notably, Super Virus 5 (SV5), carrying five oncolytic mutations, displayed the largest plaques in breast cancer cells among the mutants tested, indicating the potential for enhancing oncolytic potency through the combination of mutations. Furthermore, in a HER2+ murine breast cancer model, mice treated with SV5 exhibited superior tumor reduction and increased survival compared with those treated with PBS or T3wt. Intriguingly, SV5 did not replicate faster than T3wt in cultured cells but demonstrated a farther spread relative to T3wt, attributed to its reduced attachment to cancer cells. These findings highlight the significance of increased virus spread as a crucial mechanism for improving oncolytic virus activity. Thus, genetic modifications of reovirus hold the potential for augmenting its efficacy in cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

breast cancerimmunotherapyimproved oncolytic potencyimproved reovirus mutantlarge-plaque-forming virusoncolytic virusreovirusreovirus spreadvirus attachmentvirus spread

Autor:innen und Institutionen

  • Department of Medical Microbiology and Immunology, University of Alberta, Edmonton AB T6G 2E1, Canada.
  • Li Ka Shing Institute of Virology, University of Alberta, Edmonton AB T6G 2E1, Canada.
  • Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton AB T6G 2E1, Canada.
  • Department of Oncology, University of Alberta, Edmonton AB T6G 1Z2, Canada.

Zitieren

APA

Cristi, F., Walters, M., Narayan, N., Agopsowicz, K., Hitt, M. M., & Shmulevitz, M. (2023). Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment. Molecular Therapy - Oncolytics, 31, 100743. https://doi.org/10.1016/j.omto.2023.100743

Vancouver

Cristi F, Walters M, Narayan N, Agopsowicz K, Hitt MM, Shmulevitz M. Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment. Molecular Therapy - Oncolytics. 2023;31:100743. doi:10.1016/j.omto.2023.100743

BibTeX
@article{Cristi2023,
  author = {Cristi, Francisca and Walters, Maiah and Narayan, Nashae and Agopsowicz, Kate and Hitt, Mary M and Shmulevitz, Maya},
  title = {Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment},
  journal = {Molecular Therapy - Oncolytics},
  year = {2023},
  volume = {31},
  pages = {100743},
  doi = {10.1016/j.omto.2023.100743}
}
Kostenlos starten →